In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1896 News Items found
Patient receiving stereotactic body radiation therapy at Memorial Sloan Kettering Cancer Center.
Ablative Radiotherapy Controls Resistant Non-Small Cell Lung Cancer in Clinical Trial

Learn how highly focused, intense radiation can stop lung cancer from growing after it has spread to a small number of sites.
Dr. Lorenzo Falchi
In the Clinic
Blood Test To Identify Which Large B Cell Lymphoma Patients Are Candidates for Glofitamab Shows Promise in Clinical Trial

Learn about results from a clinical trial that found blood tests can help predict which patients with large B cell lymphoma are likely to benefit from the targeted therapy glofitamab (Columvi).
Anne and Robert Schmiedel
In the Clinic
New Treatment Results for Follicular Lymphoma Clinical Trial Presented at ASH 2023

A clinical trial of the targeted therapy mosunetuzumab (Lunsumio) has found this drug may help patients with follicular lymphoma avoid chemotherapy. Learn more about how it benefited patients who had not yet received other treatments for their lymphoma.
Omar Abdel-Wahab and Salima Benbarche
MSK’s Omar Abdel-Wahab Honored for Research Targeting Blood Cancers

MSK physician-scientist Dr. Omar Abdel-Wahab, is being honored at the 2023 American Society of Hematology (ASH) Annual Meeting with the William Dameshek Prize, which recognizes individuals who have made outstanding contributions to the field of hematology.
Suleika Jaouad is seen in the hallway of MSK with her husband Jon Batiste.
Living Life to the Fullest During Cancer: ‘American Symphony’ Documentary

Learn about life lessons during cancer in the acclaimed documentary "American Symphony," which follows Suleika Jaouad and Jon Batiste’s journey during her bone marrow transplant at Memorial Sloan Kettering.
Dana and John Avellino
FDA Approves Nirogacestat, the First-Ever Targeted Therapy for Desmoid Tumors

The FDA has approved nirogacestat (OgsiveoTM), a targeted therapy for desmoid tumors. A recent phase 3 clinical trial found that the drug significantly shrank desmoid tumors in 41% of patients. Desmoid tumors (also known as aggressive fibromatosis) are a rare type of soft tissue tumor.
scientists working in the lab
MSK Research Highlights, November 27, 2023

New MSK research finds both acupuncture and massage can benefit those with cancer-related pain; investigates relapse after CAR T cell therapy for multiple-myeloma; and showcases the power of open-source science to develop medicines against COVID-19 and other pandemics.
scientific image of mouse lung cancer cells
Lung Cancer Cells’ ‘Memories’ Suggest New Strategy For Improving Treatment

Research from the lab of cancer biologist Tuomas Tammela shows that some lung cancer cells retain a “memory” of the healthy cell where they came from — one that might be exploited to make an emerging type of lung cancer treatment called KRAS inhibition more effective.
Ming Li
How One Lab at MSK Is Working To Harness the Power of the Immune System Against Cancer

Study by study, Dr. Ming Li's lab at MSK is sharing new insights into the molecular and cellular mechanisms involved in immune regulation.
Dr. Michel Sadelain, Director of the Center for Cell Engineering, Sloan Kettering Institute.
Disrupting a Single Gene Could Improve CAR T Cell Immunotherapy, New Study Shows

Learn how disrupting a gene called SUV39H1 could make CAR T cells more powerful.